| S.No. |
Molecules |
Therapeutic applications |
| 1. |
Human insulin |
Diabetes |
| 2. |
Erythropoietin |
Treatment of anaemia |
| 3. |
Hepatitis B vaccine (recombinant surface antigen based) |
Immunization against Hepatitis B |
| 4. |
Human growth hormone |
Deficiency of growth hormone in children |
| 5. |
Interleukin 2 |
Renal cell carcinoma |
| 6. |
Interleukin 11 |
Thrombocytopenia |
| 7. |
Granulocyte Colony Stimulating Factor |
Chemotherapy induced neutropenia |
| 8. |
Granulocyte Macrophage Colony Stimulating Factor |
Chemotherapy induced neutropenia |
| 9. |
Interferon 2Alpha |
Chronic myeloid leukemia |
| 10. |
Interferon 2Beta |
Chronic myeloid leukemia, Hepatitis B and Hepatitis C |
| 11. |
Interferons Gamma |
Chronic granulomatous disease and Severe malignant osteopetrosis |
| 12. |
Streptokinase |
Acute myocardial infarction |
| 13. |
Tissue Plasminogen Activator |
Acute myocardial infarction |
| 14. |
Blood factor VIII |
Haemophilia type A |
| 15. |
Follicle stimulating hormone |
Reproductive disorders |
| 16. |
Teriparatide (Forteo) |
Osteoporosis |
| 17. |
Drerecogin (Xigris) alpha |
Severe sepsis |
| 18. |
Platelet Derived Growth Factor (PDGF) |
Bone marrow induction and osteoblasts proliferation |
| 19. |
Epidermal Growth factor (EGF) |
Mitogenesis and organ morphogenesis |
| 20. |
Eptacogalpha (r-F VIIa) r-coagulation factor |
Haemorrhages, congenital or acquired hemophilia |
